FDA Inspection 1334274 — TelaGen, LLC

TelaGen, LLC — FEI 3010763792

The FDA completed an inspection of TelaGen, LLC on Jul 28, 2026 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 28, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tallahassee, FL (United States)